Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="Battezzati, Pier Maria" or (type any "bookEditor issueEditor" and editor="Battezzati, Pie...

Add to list
Factors associated with progression and outcomes of early stage primary biliary cholangitis

Nikolaos K Gatselis, Jorn C Goet, Kalliopi Zachou, Willem J Lammers, Harry LA Janssen, Gideon Hirschfield, Christophe Corpechot, Keith D Lindor, Pietro Invernizzi, Marlyn J Mayo, et al.

(2020) CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 18(3). p.684-692
Add to list
- Journal Article
Factors Associated With Progression and Outcomes of Early Stage Primary Biliary Cholangitis

Nikolaos K. Gatselis, Jorn C. Goet, Kalliopi Zachou, Willem J. Lammers, Harry L. A. Janssen, Gideon Hirschfield, Christophe Corpechot, Keith D. Lindor, Pietro Invernizzi, Marlyn J. Mayo, et al.

(2020) CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 18(3). p.684-+
Add to list
- Journal Article
Goals of Treatment for Improved Survival in Primary Biliary Cholangitis: Treatment Target Should Be Bilirubin Within the Normal Range and Normalization of Alkaline Phosphatase

Carla F. Murillo Perez, Maren H. Harms, Keith D. Lindor, Henk R. van Buuren, Gideon M. Hirschfield, Christophe Corpechot, Adriaan J. van der Meer, Jordan J. Feld, Aliya Gulamhusein, Willem J. Lammers, et al.

(2020) AMERICAN JOURNAL OF GASTROENTEROLOGY. 115(7). p.1066-1074
Add to list
- Conference Paper
- C3
Second-line therapy is indicated in ursodeoxycholic acid-treated patients with primary biliary cholangitis and high alkaline phosphatase despite a complete globe-score response

Rozanne de Veer, Maren H Harms, Christophe Corpechot, Willem J Lammers, Douglas Thorburn, Pietro Invernizzi, Harry LA Janssen, Pier Maria Battezzati, Frederik Nevens, Keith D Lindor, et al.

(2019) HEPATOLOGY. 70(suppl. 1). p.783A-785A
Add to list
Fibrosis stage is an independent predictor of outcome in primary biliary cholangitis despite biochemical treatment response

Carla F. Murillo Perez, Gideon M. Hirschfield, Christophe Corpechot, Annarosa Floreani, Marlyn J. Mayo, Adriaan van der Meer, Cyriel Y. Ponsioen, Willem J. Lammers, Albert Pares, Pietro Invernizzi, et al.

(2019) ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 50(10). p.1127-1136
Add to list
- Conference Paper
- C3
Ursodeoxycholic acid treatment-induced globe score changes are associated with liver transplantation-free survival in patients with primary biliary cholangitis

Rozanne de Veer, Maren H Harms, Jorn Goet, Christophe Corpechot, Douglas Thorburn, Pietro Invernizzi, Willem J Lammers, Harry LA Janssen, Pier Maria Battezzati, Frederik Nevens, et al.

(2019) HEPATOLOGY. 70(suppl. 1). p.776A-777A
Add to list
- Conference Paper
- C3
Optimising trial design in late-stage primary biliary cholangitis : evaluating options for composite clinical endpoint studies

Carla Fiorella Murillo Perez, Willem J Lammers, Annarosa Floreani, Christophe Corpechot, Adriaan Van der Meer, Aliya Gulamhusein, Cyriel Ponsioen, Marco Carbone, Marlyn J Mayo, Pietro Invernizzi, et al.

(2019) HEPATOLOGY. 70(suppl. 1). p.793A-794A
Add to list
Effects of age and sex of response to ursodeoxycholic arid and transplant-free survival in patients with primary biliary cholangitis

Angela C. Cheung, Willem J. Lammers, Carla F. Murillo Perez, Henk R. van Buuren, Aliya Gulamhusein, Palak J. Trivedi, Konstantinos N. Lazaridis, Cyriel Y. Ponsioen, Annarosa Floreani, Gideon M. Hirschfield, et al.

(2019) CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 17(10). p.2076-2084.e2
Add to list
Milder disease stage in patients with primary biliary cholangitis over a 44-year period : a changing natural history

Fiorella Murillo Perez, Jorn C Goet, Willem J Lammers, Aliya Gulamhusein, Henk R van Buuren, Cyriel Y Ponsioen, Marco Carbone, Andrew Mason, Christophe Corpechot, Pietro Invernizzi, et al.

(2018) HEPATOLOGY. 67(5). p.1920-1930
Add to list
- Conference Paper
- C3
Alkaline phosphatase normalization is associated with a decreased risk for liver transplantation and death in patients with primary biliary cholangitis

Carla Fiorella Murillo Perez, Aliya Gulamhusein, Christophe Corpechot, Adriaan Van der Meer, Henk R Van Buuren, Pietro Invernizzi, Palak Trivedi, Frederik Nevens, Marlyn J Mayo, Pier Maria Battezzati, et al.

(2018) HEPATOLOGY. 68(suppl. 1). p.1085A-1086A

Academic Bibliography

Factors associated with progression and outcomes of early stage primary biliary cholangitis

Factors Associated With Progression and Outcomes of Early Stage Primary Biliary Cholangitis

Goals of Treatment for Improved Survival in Primary Biliary Cholangitis: Treatment Target Should Be Bilirubin Within the Normal Range and Normalization of Alkaline Phosphatase

Second-line therapy is indicated in ursodeoxycholic acid-treated patients with primary biliary cholangitis and high alkaline phosphatase despite a complete globe-score response

Fibrosis stage is an independent predictor of outcome in primary biliary cholangitis despite biochemical treatment response

Ursodeoxycholic acid treatment-induced globe score changes are associated with liver transplantation-free survival in patients with primary biliary cholangitis

Optimising trial design in late-stage primary biliary cholangitis : evaluating options for composite clinical endpoint studies

Effects of age and sex of response to ursodeoxycholic arid and transplant-free survival in patients with primary biliary cholangitis

Milder disease stage in patients with primary biliary cholangitis over a 44-year period : a changing natural history

Alkaline phosphatase normalization is associated with a decreased risk for liver transplantation and death in patients with primary biliary cholangitis

Contents

Support

Contact